Digestive System Diseases  >>  Kremezin (AST-120)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kremezin (AST-120) / Mitsubishi Tanabe
NCT00583076: Safety and Efficacy of AST-120 in the Treatment of Pouchitis

Completed
2
19
US
AST-120
Ocera Therapeutics
Pouchitis
03/08
05/08
NCT00587275: Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI

Terminated
2
4
US
AST-120, Celphere CP-305
Ocera Therapeutics
Gastroesophageal Reflux Disease (GERD)
06/08
06/08
NCT00583531: Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis

Terminated
2
2
US
AST-120
Ocera Therapeutics
Pouchitis
12/08
12/08
AST015, NCT00558038: Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy

Completed
2
40
US
AST-120, lactulose, Chronulac, Constilac, Constulose, Duphalac, Evalose
Ocera Therapeutics
Hepatic Encephalopathy
03/09
06/09
ASTUTE, NCT00867698: AST-120 Used to Treat Mild Hepatic Encephalopathy

Completed
2
148
US
AST-120, Spherical carbon adsorbent
Ocera Therapeutics
Mild Hepatic Encephalopathy
04/10
06/10
NCT00583128 / 2007-001950-18: Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Completed
2
117
US, Europe
AST-120, Celphere® CP-305
Ocera Therapeutics
Irritable Bowel Syndrome
05/10
06/10

Download Options